---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-079689"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:20:52.303587+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Clearside Biomedical shareholders approve doubling authorized common stock to 400M shares

## Summary
- Shareholders approved amendment to increase authorized common shares from 200M to 400M; 38.8M for, 10.3M against, 0.6M abstain.
- All three director nominees (Lasezkay, Shaffer, Gibney) were elected with >25M votes for.
- Advisory vote on executive compensation approved: 18.9M for, 3.4M against, 6.8M abstain.
- Ratification of Ernst & Young as auditor for FY2025 approved: 48.5M for, 1.2M against.

## SEC filing metadata
- accession: 0000950170-25-079689
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000095017025079689/0000950170-25-079689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000095017025079689/clsd-20250530.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-079689
- JSON: https://secwatch.observer/filing/0000950170-25-079689.json
- Plain text: https://secwatch.observer/filing/0000950170-25-079689.txt

## Key facts
- Governance Changes
  Clearside Biomedical, Inc.: Increased authorized shares of common stock from 200,000,000 to 400,000,000 (effective 2025-05-30).
  - Change: charter amendment
  - Effective: 2025-05-30
  source text: the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Amendment ”) to increase the authorized number of shares of common stock from 200,000,000 to 400,000,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1539029/000095017025079689/0000950170-25-079689-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.